Verily Health partnered with Autoimmune Registry Inc. (ARI) to expand a nationwide research registry that studies how autoimmune diseases overlap, develop, and progress over time. The registry includes more than 5,000 participants across over 100 autoimmune conditions, providing researchers with patient-reported outcomes, medical histories, and information about multiple health conditions. Verily will provide AI-supported research infrastructure, secure data management, patient enrollment, and analytics to help pharmaceutical companies, academic institutions, and other researchers identify disease patterns and potential treatment insights.
